Nutritional channels in breast cancer

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3973-3984

  Godoy, Alejandro ^a,b   Salazar, Katherine ^a   Figueroa, Carlos ^c   Smith, Gary J ^b   de los Angeles Garcia, Maria ^a   Nualart, Francisco J ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

Breast cancer; Glucose; Glucose transporter; GLUT1

Indexed keywords

GLUCOSE TRANSPORTER 1; SLC2A1 PROTEIN, HUMAN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BREAST; BREAST TUMOR; CANCER TRANSPLANTATION; CYTOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IN SITU HYBRIDIZATION; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOLOGICAL TECHNIQUES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IN SITU HYBRIDIZATION; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION;

MUS;

EID: 77649098599     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00544.x     Document Type: Article

References (47)

1. Jemal A, Siegel R, Ward E. Cancer statistics, 2008. CA Cancer J Clin. 2008, 58:71-96.
2. Birnbaum MJ, Haspel HC, Rosen OM. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science. 1987, 235:1495-8.
3. Flier JS, Mueckler MM, Usher P. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science. 1987, 235:1492-5.
4. Warburg O. On the origin of cancer cells. Science. 1956, 123:309-14.
5. Godoy A, Ulloa V, Rodriguez F. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol. 2006, 207:614-27.
6. Yamamoto T, Seino Y, Fukumoto H. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun. 1990, 170:223-30.
7. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer. 1993, 72:2979-85.
8. Gould GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochem J. 1993, 295:329-41.
9. Younes M, Lechago LV, Somoano JR. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res. 1996, 56:1164-7.
10. Younes M, Brown RW, Mody DR. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res. 1995, 15:2895-8.
11. Zamora-Leon SP, Golde DW, Concha II. Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci USA. 1996, 93:1847-52.
12. Tse NY, Hoh CK, Hawkins RA. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg. 1992, 216:27-34.
13. Minn H, Soini I. [18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer. Eur J Nucl Med. 1989, 15:61-6.
14. Nieweg OE, Kim EE, Wong WH. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer. 1993, 71:3920-5.
15. Wahl RL, Zasadny K, Helvie M. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol. 1993, 11:2101-11.
16. Levi J, Cheng Z, Gheysens O. Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem. 2007, 18:628-34.
17. Kang SS, Chun YK, Hur MH. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res. 2002, 93:1123-8.
18. Laudanski P, Swiatecka J, Kovalchuk O. Expression of GLUT1 gene in breast cancer cell lines MCF-7 and MDA-MB-231. Ginekol Pol. 2003, 74:782-5.
19. Berlangieri SU, Scott AM. Metabolic staging of lung cancer. N Engl J Med. 2000, 343:290-2.
20. Khandani AH, Whitney KD, Keller SM. Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer. Nucl Med Commun. 2007, 28:173-7.
21. Younes M, Brown RW, Stephenson M. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer. 1997, 80:1046-51.
22. Hernandez F, Navarro M, Encinas JL. The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children. J Pediatr Surg. 2005, 40:801-4.
23. Haber RS, Rathan A, Weiser KR. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer. 1998, 83:34-40.
24. Younes M, Lechago LV, Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin Cancer Res. 1996, 2:1151-4.
25. Younes M, Ertan A, Lechago LV. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia. Cancer Epidemiol Biomarkers Prev. 1997, 6:303-5.
26. Garcia MA, Carrasco M, Godoy A. Elevated expression of glucose transporter-1 in hypothalamic ependymal cells not involved in the formation of the brain-cerebrospinal fluid barrier. J Cell Biochem. 2001, 80:491-503.
27. Godoy A, Ormazabal V, Moraga-Cid G. Mechanistic insights and functional determinants of the transport cycle of the ascorbic acid transporter SVCT2. Activation by sodium and absolute dependence on bivalent cations. J Biol Chem. 2007, 282:615-24.
28. Godoy A, Watts A, Sotomayor P. Androgen receptor is causally involved in the homeostasis of the human prostate endothelial cell. Endocrinology. 2008, 149:2959-69.
29. Nualart F, Godoy A, Reinicke K. Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain. Brain Res. 1999, 824:97-104.
30. Bloom HJ. The value of histology in the prognosis and classification of breast cancer. Proc R Soc Med. 1958, 51:122-6.
31. Scarff RW. Carcinoma of the breast. Arch Middx Hosp. 1952, 2:174-83.
32. Furudoi A, Tanaka S, Haruma K. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma. Oncology. 2001, 60:162-9.
33. Zhou YL, Deng CS. Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma. Ai Zheng. 2005, 24:685-9.
34. Elston CW. The assessment of histological differentiation in breast cancer. Aust N Z J Surg. 1984, 54:11-5.
35. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957, 11:359-77.
36. Le Doussal V, Tubiana-Hulin M, Friedman S. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer. 1989, 64:1914-21.
37. Davis BW, Gelber RD, Goldhirsch A. Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer. 1986, 58:2662-70.
38. Rank F, Dombernowsky P, Jespersen NC. Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial. Cancer. 1987, 60:1299-305.
39. Haberkorn U, Ziegler SI, Oberdorfer F. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol. 1994, 21:827-34.
40. Hauptmann S, Grunewald V, Molls D. Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation. Anticancer Res. 2005, 25:3431-6.
41. Cornford EM, Hyman S, Swartz BE. The human brain GLUT1 glucose transporter: ultrastructural localization to the blood-brain barrier endothelia. J Cereb Blood Flow Metab. 1994, 14:106-12.
42. Cornford EM, Hyman S, Landaw EM. Developmental modulation of blood-brain-barrier glucose transport in the rabbit. Brain Res. 1994, 663:7-18.
43. Morgello S, Uson RR, Schwartz EJ. The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Glia. 1995, 14:43-54.
44. Verhey KJ, Hausdorff SF, Birnbaum MJ. Identification of the carboxy terminus as important for the isoform-specific subcellular targeting of glucose transporter proteins. J Cell Biol. 1993, 123:137-47.
45. Mitsumoto Y, Klip A. Development regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem. 1992, 267:4957-62.
46. Akhtar M, Robinson C, Ali MA. Secretory carcinoma of the breast in adults. Light and electron microscopic study of three cases with review of the literature. Cancer. 1983, 51:2245-54.
47. Russo J, Bradley RH, McGrath C. Scanning and transmission electron microscopy study of a human breast carcinoma cell line (MCF-7) cultured in collagen-coated cellulose sponge. Cancer Res. 1977, 37:2004-14.